Have a personal or library account? Click to login
Renal comorbidity in psoriatic arthritis patients Cover

Renal comorbidity in psoriatic arthritis patients

Open Access
|Jun 2016

References

  1. 1. Ogdie, A., Schwartzman, S. & Husni, M.E. (2015). Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol, 27(2), 118-126. doi: 10.1097/BOR.0000000000000152.10.1097/BOR.000000000000015225603040
  2. 2. Baker, J.F., Krishnan, E., Chen, L. & Schumacher, H.R. (2005). Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med, 118(8), 816-826. doi: 10.1016/j.amjmed.2005.03.043.10.1016/j.amjmed.2005.03.04316084170
  3. 3. Bruce, I.N., Schentag, C.T. & Gladman, D.D. (2000). Hyperuricemia in psoriatic arthritis: prevalence and associated features. J Clin Rheumatol, 6(1), 6-9..10.1097/00124743-200002000-00001
  4. 4. Peluso, R., Iervolino, S., Vitiello, M., Bruner, V., Lupoli, G. & Di Minno, M.N. (2015). Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol, 34(4), 745-753. doi: 10.1007/s10067-014-2652-9.10.1007/s10067-014-2652-924803233
  5. 5. Casals-Sanchez, J.L., Garcia De Yebenes Prous, M.J., Descalzo Gallego, M.A., Barrio Olmos, J.M., Carmona Ortells, L., Hernandez Garcia, C., & Grupo de Estudio em, A.R., II. (2012). Characteristics of patients with spondyloarthritis followed in rheumatology units in Spain. emAR II study. Reumatol Clin, 8(3), 107-113. doi: 10.1016/j.reuma.2012.01.006.10.1016/j.reuma.2012.01.00622465418
  6. 6. Alenius, G.M., Stegmayr, B.G., & Dahlqvist, S.R. (2001). Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol, 30(5), 271-274.10.1080/03009740175318034511727841
  7. 7. Ogdie, A., Schwartzman, S., Eder, L., Maharaj, A.B., Zisman, D., Raychaudhuri, S.P., Reddy, S.M. & Husni, E. (2014). Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations. J Rheumatol, 41(11), 2315-2322. doi: 10.3899/jrheum.140882.10.3899/jrheum.14088225362717
  8. 8. Widemann, B.C. & Adamson, P.C. (2006). Understanding and managing methotrexate nephrotoxicity. Oncologist, 11(6), 694-703. doi: 10.1634/theoncologist.11-6-69410.1634/theoncologist.11-6-69416794248
  9. 9. Dervisoglu, E., Akturk, A.S., Yildiz, K., Kiran, R. & Yilmaz, A. (2012). The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol, 44(2), 509-514. doi: 10.1007/s11255-011-9966-1.10.1007/s11255-011-9966-121505751
  10. 10. Chiu, H.Y., Huang, H.L., Li, C.H., Yin, Y.J., Chen, H.A., Hsu, S.T., Lin, S.J., Tsai, T.F. & Ho, S.Y. (2015). Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol, 173(1), 146-154. doi: 10.1111/bjd.1359910.1111/bjd.1359925511692
  11. 11. Rodrigues, C.E., Vieira, W.P., Bortoluzzo, A.B., Goncalves, C.R., da Silva, J.A., Ximenes, A.C., Bertolo, M.B., Ribeiro, S.L., Keiserman, M., Menin, R., Skare, T.L., Carneiro, S., Azevedo, V.F., Albuquerque, E.N., Bianchi, W.A., Bonfiglioli, R., Campanholo, C., Carvalho, H.M., Costa, I.P., Duarte, A.P., Kohem, C.L., Leite, N.H., Lima, S.A., Meirelles, E.S., Pereira, I.A., Pinheiro, M.M., Polito, E., Resende, G.G., Rocha, F.A., Santiago, M.B., Sauma Mde, F., Valim, V. & Sampaio-Barros, P.D. (2012). Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis. Rev Bras Reumatol, 52(3), 375-383..
  12. 12. Feldman, S.R., Zhao, Y., Shi, L., Tran, M.H. & Lu, J. (2015). Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Arthritis Care Res (Hoboken), 67(5), 708-717. doi: 10.1002/acr.2249210.1002/acr.22492502958925303478
  13. 13. Keith, D.S., Nichols, G.A., Gullion, C.M., Brown, J.B. & Smith, D.H. (2004). Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med, 164(6), 659-663. doi: 10.1001/archinte.164.6.659.10.1001/archinte.164.6.65915037495
  14. 14. Foley, R.N., Murray, A.M., Li, S., Herzog, C.A., McBean, A.M., Eggers, P.W. & Collins, A.J. (2005). Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol, 16(2), 489-495. doi: 10.1681/ASN.2004030203.10.1681/ASN.200403020315590763
  15. 15. National Kidney Foundation (2012). KDOQI clinical practice guidelines for glomerulonephritis Kidney Int.; 2(suppl 2):209-233
  16. 16. Pana, C., Tuta, L., Hanzu-Pazara, L. & Suta, M. (2015) Association between inflammation and renal involvement in psoriatic arthritis Nephrol. Dial. Transplant. 30 (suppl 3): iii519
  17. 17. Chi, C.C., Wang, J., Chen, Y.F., Wang, S.H., Chen, F.L. & Tung, T.H. (2015). Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study. J Dermatol Sci, 78(3), 232-238. doi: 10.1016/j.jdermsci.2015.03.01210.1016/j.jdermsci.2015.03.01225862150
DOI: https://doi.org/10.1515/arsm-2016-0008 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Language: English
Page range: 43 - 49
Published on: Jun 11, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Camelia Pana, Loredana Hanzu-Pazara, Daniela Duşa, Monica Tudorache, D. Fasie, Maria Suta, Liliana-Ana Tuta, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.